Imunon (IMNN) Director James Dentzer Receives Award of 6,934 Shares

What Happened
James E. Dentzer, a director of Imunon, Inc. (IMNN), was granted 6,934 shares on July 31, 2026. The award was recorded at $1.59 per share for a total value of $11,025. This transaction is coded as an acquisition/award (A) — stock issued in lieu of cash compensation for a portion of board fees, not an open-market purchase.

Key Details

• Transaction date: 2026-07-31; filing date: 2026-08-04 (filed timely).
• Price reported: $1.59 per share; total value: $11,025.
• Shares received: 6,934 shares.
• Shares owned after transaction: Not specified in the disclosed summary.
• Footnote: F1 — stock granted in lieu of cash for portion of board fees.
• Transaction type: Award/grant (routine compensation for a director), not a sale or 10b5-1 trade.

Context
Grants in lieu of cash for board fees are common director compensation and generally reflect routine corporate governance payments rather than a market sentiment signal. For retail investors, awards increase insider holdings but should be interpreted differently than open-market purchases by executives.